MStranslate

25/02/2026

Why are blood biomarkers important in multiple sclerosis research? For years, MRI scans have been the main way to monitor MS activity, but they don’t always capture what’s happening. Researchers are studying blood biomarkers, like neurofilament light (NfL), which may better reflect nerve damage in real time. A simple blood test could one day help track disease activity, monitor treatment response and even detect progression earlier. While this approach is still evolving, it represents a major step toward more personalised and less invasive MS care.

24/02/2026

A great new article in The Conversation Australia + NZ describing a new study that has suggested EBV may play a role in multiple sclerosis by altering the way that B cells behave. This feature has been authored by Dr Eanna Fennell from the University of Limerick, who was directly involved in the research project.

Epstein–Barr virus infects most adults. Understanding its role in Multiple Sclerosis could transform prevention and treatment in the future.

23/02/2026

VOTE NOW: If I had to choose, I would prefer:

• A simple blood test that could reliably monitor my MS progression in real time (react with LOVE)

• An accurate model that could predict how my MS may progress over the next 5 years (react with WOW)

Both are areas of active multiple sclerosis research, but we’d love to know what would matter more to you, so that we can tailor our content appropriately.

20/02/2026

We’re delighted to announce a new collaboration with Multiple Sclerosis Auckland, an organisation filled with passionate, dedicated people who have been long-term supporters of our work. We’re excited to embark on new projects together - finding better ways to support people living with MS across New Zealand and strengthen connections with the global MS community. Here’s to working together to make trusted information, research updates and community engagement more accessible than ever.

19/02/2026

During Patient Community Day 2025, a huge number of questions were submitted online asking about updates from the European Committee for Treatment & Research in Multiple Sclerosis (ECTRIMS) conference. Written answers are now available on the PCD website, covering many different topics related to MS research.

Access here: https://www.ectrimspatientcommunity.eu/ask-the-expert

18/02/2026

A newly published study has identified a version of a gene, HIF1A, that appears to reduce long-term disability progression and decrease smouldering inflammation in people living with multiple sclerosis. If confirmed in further studies, this new genetic finding could help uncover previously unrecognised disease pathways and open the door to more targeted and innovative therapeutic approaches.

17/02/2026

Research from Monash University and UCL has shown that high blood pressure and high cholesterol were associated with increased disability progression in people living with secondary progressive multiple sclerosis (SPMS). These findings add to growing evidence that managing other health conditions, including through healthy lifestyle choices and appropriate medical care, is an important part of overall MS management.

16/02/2026

VOTE NOW: I have greater interest in multiple sclerosis research that investigates:

• Treatments and strategies to manage symptoms on a daily basis (react with LOVE)

• Treatments and strategies to reduce long-term disability progression (react with WOW)

14/02/2026

In multiple sclerosis, myelin - the protective coating around nerves - gets damaged. Early in the disease, the body can often repair some of this through remyelination, but over time that process becomes less effective. Researchers are now working to understand why myelin repair slows down and how to overcome those barriers, with the goal of developing remyelination therapies that don’t just prevent damage, but actively restore it.

12/02/2026

Everyone experiences multiple sclerosis differently, and there’s no single “right” way to respond to a diagnosis. From time to time, we share stories of people who have found personal meaning or direction along the way. For Patti, that has meant supporting others living with MS in ways that feel right to her.

After living with multiple sclerosis for more than 35 years, Patti Bevilacqua has discovered an inner strength and resolve that helps her thrive.

11/02/2026

Results presented at ACTRIMS have shown that bazedoxifene did not significantly promote remyelination in women living with multiple sclerosis. The treatment was found to be safe and well tolerated, but its effect on myelin repair was small and did not reach statistical significance. It will now be important to see whether further analysis reveals potential benefits in specific subgroups of participants.

09/02/2026

VOTE NOW: I would prefer if MStranslate held their Facebook live events to discuss the latest in multiple sclerosis research on a weekday (react with LOVE) or a weekend (react with LIKE).

You can add more detail in the comments as to the time during the day and your location in the world to help us better determine the best time for our next broadcast.